Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke (ATAMIS): a Parallel Randomized, Open-label, Multicenter, Prospective Study
Phase of Trial: Phase 0
Latest Information Update: 18 Apr 2017
At a glance
- Drugs Aspirin (Primary) ; Clopidogrel (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms ATAMIS
- 10 Apr 2017 Status changed from not yet recruiting to recruiting.
- 23 Nov 2016 Planned initiation date changed from 1 Sep 2016 to 1 Nov 2016.
- 19 Aug 2016 New trial record